Evidence map›Paper›PMID 28202570›Full record

ArticleJournal of neurophysiology2017

AAV-mediated delivery of optogenetic constructs to the macaque brain triggers humoral immune responses.

Skyler D Mendoza, Yasmine El-Shamayleh, Gregory D Horwitz

Abstract read
In one paragraph

Article in Journal of neurophysiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Optogenetics in primate cortical networks.Frontiers in neuroanatomy · 2023
    Article
  7. Applications of chemogenetics in non-human primates.Current opinion in pharmacology · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Nonhuman Primate Optogenetics: Current Status and Future Prospects.Advances in experimental medicine and biology · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. New era of optogenetics: from the central to peripheral nervous system.Critical reviews in biochemistry and molecular biology · 2020
    Review
  19. A Step-by-Step Protocol for Optogenetic Kindling.Frontiers in neural circuits · 2020
    Article
  20. Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Skyler D MendozaDepartment of Physiology and Biophysics, Washington National Primate Research Center, University of Washington, Seattle, Washington.
Yasmine El-ShamaylehDepartment of Physiology and Biophysics, Washington National Primate Research Center, University of Washington, Seattle, Washington.
Gregory D HorwitzDepartment of Physiology and Biophysics, Washington National Primate Research Center, University of Washington, Seattle, Washington ghorwitz@u.washington.edu.ORCID 0000-0001-5130-5259
University of Washington · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
Vision Research CoreP30EY001730 · NEI · UNIVERSITY OF WASHINGTON · PI JAMES Bryant HURLEY · 1985 to 2026
$23.5M
Corticotectal transmission for express saccadesR21EY024362 · NEI · UNIVERSITY OF WASHINGTON · PI HORWITZ, GREGORY D · 2014 to 2015
$485k
NEI NIH HHS P30 EY001730NEI NIH HHS R21 EY024362NIH HHS P51 OD010425
6 · The paper itself

Abstract

Gene delivery to the primate central nervous system via recombinant adeno-associated viral vectors (AAV) allows neurophysiologists to control and observe neural activity precisely. A current limitation of this approach is variability in vector transduction efficiency. Low levels of transduction can foil experimental manipulations, prompting vector readministration. The ability to make multiple vector injections into the same animal, even in cases where successful vector transduction has already been achieved, is also desirable. However, vector readministration has consequences for humoral immunity and gene delivery that depend on vector dosage and route of administration in complex ways. As part of optogenetic experiments in rhesus monkeys, we analyzed blood sera collected before and after AAV injections into the brain and quantified neutralizing antibodies to AAV using an in vitro assay. We found that injections of AAV1 and AAV9 vectors elevated neutralizing antibody titers consistently. These immune responses were specific to the serotype injected and were long lasting. These results demonstrate that optogenetic manipulations in monkeys trigger immune responses to AAV capsids, suggesting that vector readministration may have a higher likelihood of success by avoiding serotypes injected previously.

Indexed as

Immunity, HumoralAnimalsAntibodies, NeutralizingBrainDependovirusFemaleGenetic VectorsGene Transfer TechniquesHEK293 CellsHumansMacaca mulattaMaleOptogeneticsAntibodies, NeutralizingAAV vectorsneutralizing antibodiesnonhuman primateoptogenetics

Identifiers

PMID28202570
PMCPMC5411474
OpenAlexW2588541268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.